Test Directory
| Test Code | ||||||||||||||||||||||||||||||
| 1645 | ||||||||||||||||||||||||||||||
| Test Name | ||||||||||||||||||||||||||||||
| Spinal Muscular Atrophy, Distal, X-linked 3 | ||||||||||||||||||||||||||||||
| CPT Codes | ||||||||||||||||||||||||||||||
| 81479 | ||||||||||||||||||||||||||||||
| Expected Turnaround Time | ||||||||||||||||||||||||||||||
| Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited. | ||||||||||||||||||||||||||||||
| Clinical Utility | ||||||||||||||||||||||||||||||
| Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members. | ||||||||||||||||||||||||||||||
| Specimen and Container Info | ||||||||||||||||||||||||||||||
|
Non-Prenatal Specimens
Prenatal Specimens Either specimen type below is acceptable.
NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico. |
||||||||||||||||||||||||||||||
| Transport Instructions | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Stability Requirements | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Causes for Rejection | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Methodology | ||||||||||||||||||||||||||||||
| Next Generation Sequencing and Copy Number Variation Analysis | ||||||||||||||||||||||||||||||
| Performing Location | ||||||||||||||||||||||||||||||
| Genomics - Snowdrift | ||||||||||||||||||||||||||||||
| Alternate Names | ||||||||||||||||||||||||||||||
| SMAX3 | ||||||||||||||||||||||||||||||
| Description | ||||||||||||||||||||||||||||||
|
Spinal muscular atrophy, distal, X-linked 3 (SMAX3; MIM 300489) is a recessive disorder caused by mutations in the ATP7A gene. SMAX3 is one of several distal hereditary motor neuropathies that comprise a clinically and genetically heterogeneous group affecting peripheral motor neurons. The clinical findings in SMAX3 include distal muscle weakness and atrophy, pes cavus, pes varus, gait instability, hyporeflexia and only mild distal sensory impairment. Onset is relatively late and progression is slow. Affected individuals may remain ambulatory late in life. ATP7A encodes a transmembrane copper-transporting P-type ATPase, a molecule involved in copper efflux from cells. This molecule transports copper to copper dependent enzymes synthesized within secretory compartments of cells. It is also involved in copper absorption from the gut. SMAX3 is allelic to occipital horn syndrome (OHS; MIM 304150) and Menkes disease (MK; MIM 309400). |
||||||||||||||||||||||||||||||
| Testing Schedule | ||||||||||||||||||||||||||||||
| Monday-Friday | ||||||||||||||||||||||||||||||
| Genes | ||||||||||||||||||||||||||||||
| ATP7A | ||||||||||||||||||||||||||||||
| MIM | ||||||||||||||||||||||||||||||
| 300489 | ||||||||||||||||||||||||||||||
| Disease Group | ||||||||||||||||||||||||||||||
| Neuromuscular | ||||||||||||||||||||||||||||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.